Bangladesh's Square Pharmaceuticals, Renata, and Fortune Shoes have made it to Forbes Magazine's list of 200 top public companies in the Asia-Pacific region.
The American business magazine's annual list recognized the best small and mid-sized publicly traded companies in the Asia-Pacific with sales under $1 billion.
These companies have track records of exceptional corporate performance, with one Covid-19 caveat: the list is based on full-year data as of July 7 and does not fully reflect the impact from the pandemic-led downturn, Forbes said.
Fortune Shoes has a sales volume worth $18 million, net income of $3 million, and a market value of $28 million, according to Forbes' "Asia's Best Under a Billion 2020" list.
Square Pharmaceuticals has sales of $512 million, a net income of $150 million, and a market value of $1,716 million.
Renata shows sales of $271 million, net income of $45 million, and a market value of $1,071 million.